4D MOLECULAR THERAPEUTICS IN's ticker is FDMT and the CUSIP is 35104E100. A total of 101 filers reported holding 4D MOLECULAR THERAPEUTICS IN in Q2 2023. The put-call ratio across all filers is 1.67 and the average weighting 0.2%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Itau Unibanco Holding S.A. | 1,133 | $20,473 | 0.00% |
| Squarepoint Ops LLC | 14,693 | $265,503 | 0.00% |
| NORTHERN TRUST CORP | 332,367 | $6,005,871 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 689,777 | $12,464,276 | 0.00% |
| CREDIT SUISSE AG/ | 34,617 | $625,529 | 0.00% |
| CITIGROUP INC | 58,157 | $1,050,897 | 0.00% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 266,077 | $4,808,011 | 0.00% |
| Nuveen Asset Management, LLC | 97,320 | $1,758,573 | 0.00% |
| WELLINGTON MANAGEMENT GROUP LLP | 169,084 | $3,055,348 | 0.00% |
| Invesco Ltd. | 215,576 | $3,895,459 | 0.00% |
| BlackRock Inc. | 2,914,430 | $52,663,750 | 0.00% |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 6,988 | $126,273 | 0.00% |
| Mitsubishi UFJ Asset Management Co., Ltd. | 14,458 | $261,256 | 0.00% |
| Daiwa Securities Group Inc. | 4,762 | $86 | 0.00% |
| UBS Group AG | 53,850 | $973,070 | 0.00% |
| SIGNATUREFD, LLC | 22 | $398 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 102,508 | $1,852,320 | 0.00% |
| UBS ASSET MANAGEMENT AMERICAS LLC | 10,149 | $174,462 | 0.00% |
| Impact Partnership Wealth, LLC | 57 | $1,030 | 0.00% |
| Cubist Systematic Strategies, LLC | 1 | $18 | 0.00% |
External links
This page lists 4D MOLECULAR THERAPEUTICS IN's shareholders in Q2 2023. To view 4D MOLECULAR THERAPEUTICS IN's shareholder history, click here.